• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Exploring Pharmaceutical Innovations, Trust, and Access With CVS Health's CMO

Commentary
Podcast

On this episode of Managed Care Cast, we're talking with the chief medical officer of CVS Health about recent pharmaceutical innovations, patient-provider relationships, and strategies to reduce drug costs.

On this episode of Managed Care Cast, we're talking with Sreekanth Chaguturu, MD, the chief medical officer of CVS Health.

We discuss the impact of recent pharmaceutical innovations, namely glucagon-like peptide-1 (GLP-1) receptor agonists and biosimilars, on patient health outcomes. Also, we explore the role of trust between patients and providers in adopting new medications, along with initiatives used to reduce drug prices and improve access.

Listen above or on one of these podcast services:

iTunes
TuneIn
Stitcher
Spotify

Related Videos
Lindsey Valenzuela, PharmD, APh, BCACP - screenshot by AJMC
Kelley L. Julian, PharmD, BCOP
Dr Vivek Subbiah
Lindsey Valenzuela, PharmD, APh, BCACP – screenshot by AJMC
Dr Scott Soefje
Robert Andrews, chief executive officer, Health Transformation Alliance
UPMC Title Slide Open | Image Credit: © Notebook and Maggie Shaw
Dr Vivek Subbiah
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.